Brief Report: Potent clinical and radiological response to larotrectinib in TRK fusion-driven high-grade glioma

Overview of attention for article published in British Journal of Cancer, September 2018

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

So far, Altmetric has seen 7 news stories from 7 outlets.

LOXO-292 Registrational Data Expected in 2019 LOXO-292 NDA Submission Expected in Late 2019 Enrollment of First Patient in LOXO-3…

LOXO-292 Registrational Data Expected in 2019 LOXO-292 NDA Submission Expected in Late 2019 Enrollment of First Patient in LOXO-3…

LOXO-292 Registrational Data Expected in 2019 LOXO-292 NDA Submission Expected in Late 2019 Enrollment of First Patient in LOXO-3…

LOXO-292 Registrational Data Expected in 2019 LOXO-292 NDA Submission Expected in Late 2019 Enrollment of First Patient in LOXO-3…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 3 additional news stories.